nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemfibrozil—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.144	0.189	CbGbCtD
Gemfibrozil—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.1	0.132	CbGbCtD
Gemfibrozil—CYP2C8—Progesterone—uterine cancer	0.0954	0.125	CbGbCtD
Gemfibrozil—CYP2C19—Progesterone—uterine cancer	0.0801	0.105	CbGbCtD
Gemfibrozil—CYP1A2—Progesterone—uterine cancer	0.0739	0.0969	CbGbCtD
Gemfibrozil—CYP2C9—Progesterone—uterine cancer	0.0666	0.0873	CbGbCtD
Gemfibrozil—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0584	0.0766	CbGbCtD
Gemfibrozil—CYP2C8—Etoposide—uterine cancer	0.0427	0.056	CbGbCtD
Gemfibrozil—CYP3A4—Progesterone—uterine cancer	0.0387	0.0508	CbGbCtD
Gemfibrozil—CYP1A2—Etoposide—uterine cancer	0.0331	0.0434	CbGbCtD
Gemfibrozil—CYP3A4—Etoposide—uterine cancer	0.0173	0.0227	CbGbCtD
Gemfibrozil—CYP3A4—Doxorubicin—uterine cancer	0.0118	0.0155	CbGbCtD
Gemfibrozil—Shock—Medroxyprogesterone Acetate—uterine cancer	0.000659	0.00326	CcSEcCtD
Gemfibrozil—Somnolence—Progesterone—uterine cancer	0.000657	0.00326	CcSEcCtD
Gemfibrozil—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.000657	0.00325	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000656	0.00325	CcSEcCtD
Gemfibrozil—Dyspepsia—Progesterone—uterine cancer	0.000651	0.00322	CcSEcCtD
Gemfibrozil—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.000651	0.00322	CcSEcCtD
Gemfibrozil—Alopecia—Dactinomycin—uterine cancer	0.00065	0.00322	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Progesterone—uterine cancer	0.000638	0.00316	CcSEcCtD
Gemfibrozil—Fatigue—Progesterone—uterine cancer	0.000638	0.00316	CcSEcCtD
Gemfibrozil—Constipation—Progesterone—uterine cancer	0.000632	0.00313	CcSEcCtD
Gemfibrozil—Pain—Progesterone—uterine cancer	0.000632	0.00313	CcSEcCtD
Gemfibrozil—Pancytopenia—Etoposide—uterine cancer	0.000632	0.00313	CcSEcCtD
Gemfibrozil—Blood bilirubin increased—Epirubicin—uterine cancer	0.000628	0.00311	CcSEcCtD
Gemfibrozil—Jaundice cholestatic—Doxorubicin—uterine cancer	0.000626	0.0031	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00061	0.00302	CcSEcCtD
Gemfibrozil—Feeling abnormal—Progesterone—uterine cancer	0.000609	0.00302	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Progesterone—uterine cancer	0.000605	0.00299	CcSEcCtD
Gemfibrozil—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000602	0.00298	CcSEcCtD
Gemfibrozil—Musculoskeletal pain—Epirubicin—uterine cancer	0.000602	0.00298	CcSEcCtD
Gemfibrozil—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000596	0.00295	CcSEcCtD
Gemfibrozil—Phosphatase alkaline increased—Epirubicin—uterine cancer	0.000594	0.00294	CcSEcCtD
Gemfibrozil—Anaemia—Dactinomycin—uterine cancer	0.000592	0.00293	CcSEcCtD
Gemfibrozil—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00059	0.00292	CcSEcCtD
Gemfibrozil—Urticaria—Progesterone—uterine cancer	0.000587	0.00291	CcSEcCtD
Gemfibrozil—Abdominal pain—Progesterone—uterine cancer	0.000585	0.00289	CcSEcCtD
Gemfibrozil—Renal failure—Etoposide—uterine cancer	0.000583	0.00289	CcSEcCtD
Gemfibrozil—Blood bilirubin increased—Doxorubicin—uterine cancer	0.000581	0.00288	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Etoposide—uterine cancer	0.000581	0.00288	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000578	0.00286	CcSEcCtD
Gemfibrozil—Jaundice—Etoposide—uterine cancer	0.000578	0.00286	CcSEcCtD
Gemfibrozil—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000578	0.00286	CcSEcCtD
Gemfibrozil—Leukopenia—Dactinomycin—uterine cancer	0.000573	0.00284	CcSEcCtD
Gemfibrozil—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000573	0.00284	CcSEcCtD
Gemfibrozil—Colitis—Epirubicin—uterine cancer	0.000571	0.00283	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Etoposide—uterine cancer	0.000561	0.00278	CcSEcCtD
Gemfibrozil—Musculoskeletal pain—Doxorubicin—uterine cancer	0.000557	0.00276	CcSEcCtD
Gemfibrozil—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000552	0.00273	CcSEcCtD
Gemfibrozil—Phosphatase alkaline increased—Doxorubicin—uterine cancer	0.00055	0.00272	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000548	0.00271	CcSEcCtD
Gemfibrozil—Myalgia—Dactinomycin—uterine cancer	0.000545	0.0027	CcSEcCtD
Gemfibrozil—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000532	0.00264	CcSEcCtD
Gemfibrozil—Asthenia—Progesterone—uterine cancer	0.000531	0.00263	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Etoposide—uterine cancer	0.00053	0.00262	CcSEcCtD
Gemfibrozil—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00053	0.00262	CcSEcCtD
Gemfibrozil—Colitis—Doxorubicin—uterine cancer	0.000528	0.00261	CcSEcCtD
Gemfibrozil—Pruritus—Progesterone—uterine cancer	0.000523	0.00259	CcSEcCtD
Gemfibrozil—Oedema—Dactinomycin—uterine cancer	0.000523	0.00259	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Dactinomycin—uterine cancer	0.000512	0.00253	CcSEcCtD
Gemfibrozil—Diarrhoea—Progesterone—uterine cancer	0.000506	0.00251	CcSEcCtD
Gemfibrozil—Eye disorder—Etoposide—uterine cancer	0.000498	0.00246	CcSEcCtD
Gemfibrozil—Blood alkaline phosphatase increased—Epirubicin—uterine cancer	0.000496	0.00246	CcSEcCtD
Gemfibrozil—Photosensitivity—Epirubicin—uterine cancer	0.000491	0.00243	CcSEcCtD
Gemfibrozil—Dizziness—Progesterone—uterine cancer	0.000489	0.00242	CcSEcCtD
Gemfibrozil—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000481	0.00238	CcSEcCtD
Gemfibrozil—Eczema—Epirubicin—uterine cancer	0.00048	0.00238	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Etoposide—uterine cancer	0.00048	0.00238	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000476	0.00236	CcSEcCtD
Gemfibrozil—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000474	0.00235	CcSEcCtD
Gemfibrozil—Alopecia—Etoposide—uterine cancer	0.00047	0.00233	CcSEcCtD
Gemfibrozil—Vomiting—Progesterone—uterine cancer	0.00047	0.00233	CcSEcCtD
Gemfibrozil—Rash—Progesterone—uterine cancer	0.000466	0.00231	CcSEcCtD
Gemfibrozil—Dermatitis—Progesterone—uterine cancer	0.000466	0.00231	CcSEcCtD
Gemfibrozil—Headache—Progesterone—uterine cancer	0.000463	0.00229	CcSEcCtD
Gemfibrozil—Blood alkaline phosphatase increased—Doxorubicin—uterine cancer	0.000459	0.00227	CcSEcCtD
Gemfibrozil—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000458	0.00227	CcSEcCtD
Gemfibrozil—Dermatitis exfoliative—Epirubicin—uterine cancer	0.000457	0.00226	CcSEcCtD
Gemfibrozil—Photosensitivity—Doxorubicin—uterine cancer	0.000455	0.00225	CcSEcCtD
Gemfibrozil—Dysgeusia—Etoposide—uterine cancer	0.000454	0.00225	CcSEcCtD
Gemfibrozil—Fatigue—Dactinomycin—uterine cancer	0.000451	0.00223	CcSEcCtD
Gemfibrozil—Pain—Dactinomycin—uterine cancer	0.000447	0.00221	CcSEcCtD
Gemfibrozil—Eczema—Doxorubicin—uterine cancer	0.000444	0.0022	CcSEcCtD
Gemfibrozil—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000443	0.00219	CcSEcCtD
Gemfibrozil—Nausea—Progesterone—uterine cancer	0.000439	0.00218	CcSEcCtD
Gemfibrozil—Feeling abnormal—Dactinomycin—uterine cancer	0.000431	0.00213	CcSEcCtD
Gemfibrozil—Anaemia—Etoposide—uterine cancer	0.000428	0.00212	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000427	0.00212	CcSEcCtD
Gemfibrozil—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000426	0.00211	CcSEcCtD
Gemfibrozil—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.000423	0.00209	CcSEcCtD
Gemfibrozil—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000422	0.00209	CcSEcCtD
Gemfibrozil—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000422	0.00209	CcSEcCtD
Gemfibrozil—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00042	0.00208	CcSEcCtD
Gemfibrozil—Vertigo—Etoposide—uterine cancer	0.000416	0.00206	CcSEcCtD
Gemfibrozil—Leukopenia—Etoposide—uterine cancer	0.000415	0.00205	CcSEcCtD
Gemfibrozil—Abdominal pain—Dactinomycin—uterine cancer	0.000413	0.00205	CcSEcCtD
Gemfibrozil—PPARA—epithelium—uterine cancer	0.00041	0.122	CbGeAlD
Gemfibrozil—Loss of consciousness—Etoposide—uterine cancer	0.000407	0.00202	CcSEcCtD
Gemfibrozil—Cough—Etoposide—uterine cancer	0.000404	0.002	CcSEcCtD
Gemfibrozil—Convulsion—Etoposide—uterine cancer	0.000402	0.00199	CcSEcCtD
Gemfibrozil—Liver function test abnormal—Epirubicin—uterine cancer	0.000398	0.00197	CcSEcCtD
Gemfibrozil—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000398	0.00197	CcSEcCtD
Gemfibrozil—PPARA—smooth muscle tissue—uterine cancer	0.000396	0.117	CbGeAlD
Gemfibrozil—Chest pain—Etoposide—uterine cancer	0.000395	0.00195	CcSEcCtD
Gemfibrozil—Abdominal pain upper—Epirubicin—uterine cancer	0.000394	0.00195	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000392	0.00194	CcSEcCtD
Gemfibrozil—Breast disorder—Epirubicin—uterine cancer	0.00039	0.00193	CcSEcCtD
Gemfibrozil—Nasopharyngitis—Epirubicin—uterine cancer	0.000386	0.00191	CcSEcCtD
Gemfibrozil—Confusional state—Etoposide—uterine cancer	0.000381	0.00189	CcSEcCtD
Gemfibrozil—PPARA—renal system—uterine cancer	0.000381	0.113	CbGeAlD
Gemfibrozil—Muscular weakness—Epirubicin—uterine cancer	0.00038	0.00188	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Etoposide—uterine cancer	0.000378	0.00187	CcSEcCtD
Gemfibrozil—Asthenia—Dactinomycin—uterine cancer	0.000375	0.00186	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Etoposide—uterine cancer	0.00037	0.00183	CcSEcCtD
Gemfibrozil—Eosinophilia—Epirubicin—uterine cancer	0.000369	0.00183	CcSEcCtD
Gemfibrozil—Liver function test abnormal—Doxorubicin—uterine cancer	0.000369	0.00183	CcSEcCtD
Gemfibrozil—Skin disorder—Etoposide—uterine cancer	0.000367	0.00182	CcSEcCtD
Gemfibrozil—Pancreatitis—Epirubicin—uterine cancer	0.000366	0.00181	CcSEcCtD
Gemfibrozil—Abdominal pain upper—Doxorubicin—uterine cancer	0.000365	0.00181	CcSEcCtD
Gemfibrozil—Breast disorder—Doxorubicin—uterine cancer	0.000361	0.00179	CcSEcCtD
Gemfibrozil—Diarrhoea—Dactinomycin—uterine cancer	0.000358	0.00177	CcSEcCtD
Gemfibrozil—Nasopharyngitis—Doxorubicin—uterine cancer	0.000357	0.00177	CcSEcCtD
Gemfibrozil—Pancytopenia—Epirubicin—uterine cancer	0.000354	0.00175	CcSEcCtD
Gemfibrozil—Muscular weakness—Doxorubicin—uterine cancer	0.000352	0.00174	CcSEcCtD
Gemfibrozil—Eosinophilia—Doxorubicin—uterine cancer	0.000342	0.00169	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Epirubicin—uterine cancer	0.00034	0.00169	CcSEcCtD
Gemfibrozil—Paraesthesia—Etoposide—uterine cancer	0.00034	0.00168	CcSEcCtD
Gemfibrozil—Pancreatitis—Doxorubicin—uterine cancer	0.000338	0.00168	CcSEcCtD
Gemfibrozil—Weight decreased—Epirubicin—uterine cancer	0.000337	0.00167	CcSEcCtD
Gemfibrozil—Somnolence—Etoposide—uterine cancer	0.000336	0.00167	CcSEcCtD
Gemfibrozil—Vomiting—Dactinomycin—uterine cancer	0.000332	0.00165	CcSEcCtD
Gemfibrozil—Rash—Dactinomycin—uterine cancer	0.00033	0.00163	CcSEcCtD
Gemfibrozil—Pancytopenia—Doxorubicin—uterine cancer	0.000328	0.00162	CcSEcCtD
Gemfibrozil—Renal failure—Epirubicin—uterine cancer	0.000327	0.00162	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Etoposide—uterine cancer	0.000327	0.00162	CcSEcCtD
Gemfibrozil—Fatigue—Etoposide—uterine cancer	0.000326	0.00161	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Epirubicin—uterine cancer	0.000326	0.00161	CcSEcCtD
Gemfibrozil—Jaundice—Epirubicin—uterine cancer	0.000324	0.0016	CcSEcCtD
Gemfibrozil—Constipation—Etoposide—uterine cancer	0.000323	0.0016	CcSEcCtD
Gemfibrozil—Pain—Etoposide—uterine cancer	0.000323	0.0016	CcSEcCtD
Gemfibrozil—Urinary tract infection—Epirubicin—uterine cancer	0.000323	0.0016	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000315	0.00156	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Epirubicin—uterine cancer	0.000314	0.00156	CcSEcCtD
Gemfibrozil—Weight decreased—Doxorubicin—uterine cancer	0.000312	0.00155	CcSEcCtD
Gemfibrozil—Feeling abnormal—Etoposide—uterine cancer	0.000312	0.00154	CcSEcCtD
Gemfibrozil—Nausea—Dactinomycin—uterine cancer	0.00031	0.00154	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Etoposide—uterine cancer	0.000309	0.00153	CcSEcCtD
Gemfibrozil—PPARA—female reproductive system—uterine cancer	0.000305	0.0903	CbGeAlD
Gemfibrozil—Renal failure—Doxorubicin—uterine cancer	0.000302	0.0015	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000302	0.00149	CcSEcCtD
Gemfibrozil—Urticaria—Etoposide—uterine cancer	0.000301	0.00149	CcSEcCtD
Gemfibrozil—Jaundice—Doxorubicin—uterine cancer	0.0003	0.00148	CcSEcCtD
Gemfibrozil—Rhinitis—Epirubicin—uterine cancer	0.000299	0.00148	CcSEcCtD
Gemfibrozil—Abdominal pain—Etoposide—uterine cancer	0.000299	0.00148	CcSEcCtD
Gemfibrozil—Urinary tract infection—Doxorubicin—uterine cancer	0.000299	0.00148	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Epirubicin—uterine cancer	0.000297	0.00147	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Epirubicin—uterine cancer	0.000293	0.00145	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000291	0.00144	CcSEcCtD
Gemfibrozil—Eye disorder—Epirubicin—uterine cancer	0.000279	0.00138	CcSEcCtD
Gemfibrozil—PPARA—female gonad—uterine cancer	0.000277	0.0822	CbGeAlD
Gemfibrozil—Rhinitis—Doxorubicin—uterine cancer	0.000277	0.00137	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Doxorubicin—uterine cancer	0.000275	0.00136	CcSEcCtD
Gemfibrozil—Asthenia—Etoposide—uterine cancer	0.000271	0.00134	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Doxorubicin—uterine cancer	0.000271	0.00134	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Epirubicin—uterine cancer	0.000269	0.00133	CcSEcCtD
Gemfibrozil—Pruritus—Etoposide—uterine cancer	0.000268	0.00133	CcSEcCtD
Gemfibrozil—Alopecia—Epirubicin—uterine cancer	0.000264	0.00131	CcSEcCtD
Gemfibrozil—Mental disorder—Epirubicin—uterine cancer	0.000261	0.00129	CcSEcCtD
Gemfibrozil—Diarrhoea—Etoposide—uterine cancer	0.000259	0.00128	CcSEcCtD
Gemfibrozil—Eye disorder—Doxorubicin—uterine cancer	0.000258	0.00128	CcSEcCtD
Gemfibrozil—Flatulence—Epirubicin—uterine cancer	0.000256	0.00127	CcSEcCtD
Gemfibrozil—Tension—Epirubicin—uterine cancer	0.000255	0.00126	CcSEcCtD
Gemfibrozil—Dysgeusia—Epirubicin—uterine cancer	0.000254	0.00126	CcSEcCtD
Gemfibrozil—Nervousness—Epirubicin—uterine cancer	0.000252	0.00125	CcSEcCtD
Gemfibrozil—Dizziness—Etoposide—uterine cancer	0.00025	0.00124	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Doxorubicin—uterine cancer	0.000249	0.00123	CcSEcCtD
Gemfibrozil—Vision blurred—Epirubicin—uterine cancer	0.000245	0.00121	CcSEcCtD
Gemfibrozil—Alopecia—Doxorubicin—uterine cancer	0.000244	0.00121	CcSEcCtD
Gemfibrozil—SLCO1B1—renal system—uterine cancer	0.000243	0.0719	CbGeAlD
Gemfibrozil—Mental disorder—Doxorubicin—uterine cancer	0.000242	0.0012	CcSEcCtD
Gemfibrozil—Vomiting—Etoposide—uterine cancer	0.000241	0.00119	CcSEcCtD
Gemfibrozil—Anaemia—Epirubicin—uterine cancer	0.00024	0.00119	CcSEcCtD
Gemfibrozil—Rash—Etoposide—uterine cancer	0.000239	0.00118	CcSEcCtD
Gemfibrozil—Dermatitis—Etoposide—uterine cancer	0.000238	0.00118	CcSEcCtD
Gemfibrozil—Headache—Etoposide—uterine cancer	0.000237	0.00117	CcSEcCtD
Gemfibrozil—Flatulence—Doxorubicin—uterine cancer	0.000237	0.00117	CcSEcCtD
Gemfibrozil—Tension—Doxorubicin—uterine cancer	0.000236	0.00117	CcSEcCtD
Gemfibrozil—Dysgeusia—Doxorubicin—uterine cancer	0.000235	0.00117	CcSEcCtD
Gemfibrozil—Nervousness—Doxorubicin—uterine cancer	0.000233	0.00116	CcSEcCtD
Gemfibrozil—Vertigo—Epirubicin—uterine cancer	0.000233	0.00116	CcSEcCtD
Gemfibrozil—Syncope—Epirubicin—uterine cancer	0.000233	0.00115	CcSEcCtD
Gemfibrozil—Leukopenia—Epirubicin—uterine cancer	0.000233	0.00115	CcSEcCtD
Gemfibrozil—Loss of consciousness—Epirubicin—uterine cancer	0.000228	0.00113	CcSEcCtD
Gemfibrozil—Cough—Epirubicin—uterine cancer	0.000227	0.00112	CcSEcCtD
Gemfibrozil—Vision blurred—Doxorubicin—uterine cancer	0.000227	0.00112	CcSEcCtD
Gemfibrozil—Convulsion—Epirubicin—uterine cancer	0.000225	0.00111	CcSEcCtD
Gemfibrozil—Nausea—Etoposide—uterine cancer	0.000225	0.00111	CcSEcCtD
Gemfibrozil—Anaemia—Doxorubicin—uterine cancer	0.000222	0.0011	CcSEcCtD
Gemfibrozil—Myalgia—Epirubicin—uterine cancer	0.000221	0.0011	CcSEcCtD
Gemfibrozil—Chest pain—Epirubicin—uterine cancer	0.000221	0.0011	CcSEcCtD
Gemfibrozil—Arthralgia—Epirubicin—uterine cancer	0.000221	0.0011	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.00022	0.00109	CcSEcCtD
Gemfibrozil—Vertigo—Doxorubicin—uterine cancer	0.000216	0.00107	CcSEcCtD
Gemfibrozil—Syncope—Doxorubicin—uterine cancer	0.000216	0.00107	CcSEcCtD
Gemfibrozil—Leukopenia—Doxorubicin—uterine cancer	0.000215	0.00107	CcSEcCtD
Gemfibrozil—Confusional state—Epirubicin—uterine cancer	0.000214	0.00106	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Epirubicin—uterine cancer	0.000212	0.00105	CcSEcCtD
Gemfibrozil—Oedema—Epirubicin—uterine cancer	0.000212	0.00105	CcSEcCtD
Gemfibrozil—Loss of consciousness—Doxorubicin—uterine cancer	0.000211	0.00105	CcSEcCtD
Gemfibrozil—Cough—Doxorubicin—uterine cancer	0.00021	0.00104	CcSEcCtD
Gemfibrozil—Shock—Epirubicin—uterine cancer	0.000209	0.00103	CcSEcCtD
Gemfibrozil—Convulsion—Doxorubicin—uterine cancer	0.000208	0.00103	CcSEcCtD
Gemfibrozil—Nervous system disorder—Epirubicin—uterine cancer	0.000208	0.00103	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Epirubicin—uterine cancer	0.000208	0.00103	CcSEcCtD
Gemfibrozil—Skin disorder—Epirubicin—uterine cancer	0.000206	0.00102	CcSEcCtD
Gemfibrozil—Arthralgia—Doxorubicin—uterine cancer	0.000205	0.00101	CcSEcCtD
Gemfibrozil—Chest pain—Doxorubicin—uterine cancer	0.000205	0.00101	CcSEcCtD
Gemfibrozil—Myalgia—Doxorubicin—uterine cancer	0.000205	0.00101	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000203	0.00101	CcSEcCtD
Gemfibrozil—Confusional state—Doxorubicin—uterine cancer	0.000198	0.00098	CcSEcCtD
Gemfibrozil—Oedema—Doxorubicin—uterine cancer	0.000196	0.000972	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Doxorubicin—uterine cancer	0.000196	0.000972	CcSEcCtD
Gemfibrozil—SLCO1B1—female reproductive system—uterine cancer	0.000194	0.0576	CbGeAlD
Gemfibrozil—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000193	0.000957	CcSEcCtD
Gemfibrozil—Shock—Doxorubicin—uterine cancer	0.000193	0.000956	CcSEcCtD
Gemfibrozil—Nervous system disorder—Doxorubicin—uterine cancer	0.000192	0.000953	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Doxorubicin—uterine cancer	0.000192	0.000951	CcSEcCtD
Gemfibrozil—Skin disorder—Doxorubicin—uterine cancer	0.000191	0.000944	CcSEcCtD
Gemfibrozil—Paraesthesia—Epirubicin—uterine cancer	0.00019	0.000943	CcSEcCtD
Gemfibrozil—Somnolence—Epirubicin—uterine cancer	0.000189	0.000933	CcSEcCtD
Gemfibrozil—Dyspepsia—Epirubicin—uterine cancer	0.000187	0.000924	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000183	0.000907	CcSEcCtD
Gemfibrozil—Fatigue—Epirubicin—uterine cancer	0.000183	0.000905	CcSEcCtD
Gemfibrozil—Constipation—Epirubicin—uterine cancer	0.000181	0.000898	CcSEcCtD
Gemfibrozil—Pain—Epirubicin—uterine cancer	0.000181	0.000898	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000179	0.000885	CcSEcCtD
Gemfibrozil—PPARA—lymph node—uterine cancer	0.000178	0.0528	CbGeAlD
Gemfibrozil—Paraesthesia—Doxorubicin—uterine cancer	0.000176	0.000872	CcSEcCtD
Gemfibrozil—Feeling abnormal—Epirubicin—uterine cancer	0.000175	0.000865	CcSEcCtD
Gemfibrozil—Somnolence—Doxorubicin—uterine cancer	0.000174	0.000864	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Epirubicin—uterine cancer	0.000173	0.000859	CcSEcCtD
Gemfibrozil—Dyspepsia—Doxorubicin—uterine cancer	0.000173	0.000855	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000169	0.000839	CcSEcCtD
Gemfibrozil—Fatigue—Doxorubicin—uterine cancer	0.000169	0.000838	CcSEcCtD
Gemfibrozil—Urticaria—Epirubicin—uterine cancer	0.000168	0.000834	CcSEcCtD
Gemfibrozil—Constipation—Doxorubicin—uterine cancer	0.000168	0.000831	CcSEcCtD
Gemfibrozil—Pain—Doxorubicin—uterine cancer	0.000168	0.000831	CcSEcCtD
Gemfibrozil—Abdominal pain—Epirubicin—uterine cancer	0.000168	0.00083	CcSEcCtD
Gemfibrozil—Feeling abnormal—Doxorubicin—uterine cancer	0.000162	0.000801	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Doxorubicin—uterine cancer	0.00016	0.000794	CcSEcCtD
Gemfibrozil—Urticaria—Doxorubicin—uterine cancer	0.000156	0.000772	CcSEcCtD
Gemfibrozil—Abdominal pain—Doxorubicin—uterine cancer	0.000155	0.000768	CcSEcCtD
Gemfibrozil—Asthenia—Epirubicin—uterine cancer	0.000152	0.000753	CcSEcCtD
Gemfibrozil—Pruritus—Epirubicin—uterine cancer	0.00015	0.000743	CcSEcCtD
Gemfibrozil—Diarrhoea—Epirubicin—uterine cancer	0.000145	0.000718	CcSEcCtD
Gemfibrozil—Asthenia—Doxorubicin—uterine cancer	0.000141	0.000697	CcSEcCtD
Gemfibrozil—Dizziness—Epirubicin—uterine cancer	0.00014	0.000694	CcSEcCtD
Gemfibrozil—Pruritus—Doxorubicin—uterine cancer	0.000139	0.000687	CcSEcCtD
Gemfibrozil—CYP2C8—renal system—uterine cancer	0.000138	0.0409	CbGeAlD
Gemfibrozil—Vomiting—Epirubicin—uterine cancer	0.000135	0.000668	CcSEcCtD
Gemfibrozil—Diarrhoea—Doxorubicin—uterine cancer	0.000134	0.000665	CcSEcCtD
Gemfibrozil—Rash—Epirubicin—uterine cancer	0.000134	0.000662	CcSEcCtD
Gemfibrozil—Dermatitis—Epirubicin—uterine cancer	0.000134	0.000661	CcSEcCtD
Gemfibrozil—CYP2C8—endometrium—uterine cancer	0.000133	0.0395	CbGeAlD
Gemfibrozil—Headache—Epirubicin—uterine cancer	0.000133	0.000658	CcSEcCtD
Gemfibrozil—Dizziness—Doxorubicin—uterine cancer	0.00013	0.000642	CcSEcCtD
Gemfibrozil—CYP1A2—renal system—uterine cancer	0.000129	0.0382	CbGeAlD
Gemfibrozil—Nausea—Epirubicin—uterine cancer	0.000126	0.000624	CcSEcCtD
Gemfibrozil—Vomiting—Doxorubicin—uterine cancer	0.000125	0.000618	CcSEcCtD
Gemfibrozil—Rash—Doxorubicin—uterine cancer	0.000124	0.000613	CcSEcCtD
Gemfibrozil—Dermatitis—Doxorubicin—uterine cancer	0.000124	0.000612	CcSEcCtD
Gemfibrozil—Headache—Doxorubicin—uterine cancer	0.000123	0.000609	CcSEcCtD
Gemfibrozil—CYP1A2—Metapathway biotransformation—AKR1B1—uterine cancer	0.000118	0.00367	CbGpPWpGaD
Gemfibrozil—PPARA—Generic Transcription Pathway—ESR2—uterine cancer	0.000118	0.00365	CbGpPWpGaD
Gemfibrozil—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	0.000117	0.00363	CbGpPWpGaD
Gemfibrozil—Nausea—Doxorubicin—uterine cancer	0.000117	0.000577	CcSEcCtD
Gemfibrozil—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000116	0.00361	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000115	0.00358	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000115	0.00358	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000115	0.00358	CbGpPWpGaD
Gemfibrozil—CYP2C19—vagina—uterine cancer	0.000115	0.0339	CbGeAlD
Gemfibrozil—CYP2C19—Metapathway biotransformation—AKR1C1—uterine cancer	0.000111	0.00346	CbGpPWpGaD
Gemfibrozil—CYP2C8—female reproductive system—uterine cancer	0.000111	0.0327	CbGeAlD
Gemfibrozil—CYP2C8—Metapathway biotransformation—GPX3—uterine cancer	0.000109	0.0034	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000109	0.0034	CbGpPWpGaD
Gemfibrozil—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000104	0.00323	CbGpPWpGaD
Gemfibrozil—CYP2C8—Biological oxidations—CYP11A1—uterine cancer	0.000103	0.0032	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metapathway biotransformation—CYP11A1—uterine cancer	0.000102	0.00316	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metapathway biotransformation—AKR1C1—uterine cancer	0.000101	0.00315	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—uterine cancer	0.000101	0.00314	CbGpPWpGaD
Gemfibrozil—CYP2C8—vagina—uterine cancer	0.0001	0.0296	CbGeAlD
Gemfibrozil—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	9.93e-05	0.00308	CbGpPWpGaD
Gemfibrozil—CYP2C9—female reproductive system—uterine cancer	9.82e-05	0.0291	CbGeAlD
Gemfibrozil—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	9.81e-05	0.00305	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metapathway biotransformation—GPX3—uterine cancer	9.77e-05	0.00303	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metapathway biotransformation—AKR1C3—uterine cancer	9.6e-05	0.00298	CbGpPWpGaD
Gemfibrozil—PPARA—Generic Transcription Pathway—CDKN2B—uterine cancer	9.58e-05	0.00297	CbGpPWpGaD
Gemfibrozil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	9.45e-05	0.00294	CbGpPWpGaD
Gemfibrozil—CYP3A4—renal system—uterine cancer	9.35e-05	0.0277	CbGeAlD
Gemfibrozil—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	9.33e-05	0.0029	CbGpPWpGaD
Gemfibrozil—CYP2C19—Biological oxidations—CYP11A1—uterine cancer	9.2e-05	0.00286	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	9.15e-05	0.00284	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	9.12e-05	0.00283	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—AKR1B1—uterine cancer	9.09e-05	0.00282	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—STAR—uterine cancer	9.09e-05	0.00282	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metapathway biotransformation—CYP11A1—uterine cancer	9.07e-05	0.00282	CbGpPWpGaD
Gemfibrozil—PPARA—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	8.99e-05	0.00279	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	8.98e-05	0.00279	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metapathway biotransformation—GPX3—uterine cancer	8.91e-05	0.00277	CbGpPWpGaD
Gemfibrozil—PPARA—Generic Transcription Pathway—SMAD3—uterine cancer	8.74e-05	0.00272	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metapathway biotransformation—AKR1C1—uterine cancer	8.67e-05	0.00269	CbGpPWpGaD
Gemfibrozil—PPARA—Circadian rythm related genes—PTEN—uterine cancer	8.63e-05	0.00268	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metapathway biotransformation—AKR1C3—uterine cancer	8.57e-05	0.00266	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	8.45e-05	0.00262	CbGpPWpGaD
Gemfibrozil—CYP2C9—Biological oxidations—CYP11A1—uterine cancer	8.39e-05	0.00261	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metapathway biotransformation—CYP11A1—uterine cancer	8.27e-05	0.00257	CbGpPWpGaD
Gemfibrozil—PPARA—Circadian rythm related genes—EP300—uterine cancer	8.23e-05	0.00256	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—SMAD3—uterine cancer	8.23e-05	0.00256	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	8.17e-05	0.00254	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metapathway biotransformation—AKR1C3—uterine cancer	7.81e-05	0.00243	CbGpPWpGaD
Gemfibrozil—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	7.66e-05	0.00238	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metapathway biotransformation—GPX3—uterine cancer	7.61e-05	0.00236	CbGpPWpGaD
Gemfibrozil—CYP2C8—Biological oxidations—CYP19A1—uterine cancer	7.58e-05	0.00236	CbGpPWpGaD
Gemfibrozil—CYP3A4—female reproductive system—uterine cancer	7.49e-05	0.0222	CbGeAlD
Gemfibrozil—CYP2C8—Metapathway biotransformation—CYP19A1—uterine cancer	7.48e-05	0.00232	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	7.45e-05	0.00231	CbGpPWpGaD
Gemfibrozil—CYP1A2—Biological oxidations—CYP11A1—uterine cancer	7.17e-05	0.00223	CbGpPWpGaD
Gemfibrozil—PPARA—Generic Transcription Pathway—ESR1—uterine cancer	7.14e-05	0.00222	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—POLD1—uterine cancer	7.13e-05	0.00221	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—SRD5A2—uterine cancer	7.09e-05	0.0022	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—NDUFB11—uterine cancer	7.09e-05	0.0022	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metapathway biotransformation—CYP11A1—uterine cancer	7.07e-05	0.0022	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	6.89e-05	0.00214	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	6.88e-05	0.00214	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	6.88e-05	0.00214	CbGpPWpGaD
Gemfibrozil—CYP2C19—Biological oxidations—CYP19A1—uterine cancer	6.77e-05	0.0021	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—MET—uterine cancer	6.74e-05	0.00209	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	6.69e-05	0.00208	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metapathway biotransformation—AKR1C3—uterine cancer	6.68e-05	0.00207	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metapathway biotransformation—CYP19A1—uterine cancer	6.68e-05	0.00207	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—AKR1C1—uterine cancer	6.67e-05	0.00207	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	6.62e-05	0.00205	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—STAR—uterine cancer	6.62e-05	0.00205	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	6.51e-05	0.00202	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—PGR—uterine cancer	6.43e-05	0.002	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	6.36e-05	0.00198	CbGpPWpGaD
Gemfibrozil—CYP2C9—Biological oxidations—CYP19A1—uterine cancer	6.17e-05	0.00192	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—EZH2—uterine cancer	6.11e-05	0.0019	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metapathway biotransformation—CYP19A1—uterine cancer	6.09e-05	0.00189	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	6.04e-05	0.00188	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	6.04e-05	0.00188	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—RRM2—uterine cancer	5.94e-05	0.00185	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—STAR—uterine cancer	5.9e-05	0.00183	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	5.9e-05	0.00183	CbGpPWpGaD
Gemfibrozil—PPARA—Circadian rythm related genes—TP53—uterine cancer	5.89e-05	0.00183	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	5.88e-05	0.00183	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—DCN—uterine cancer	5.77e-05	0.00179	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	5.72e-05	0.00178	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—ESR2—uterine cancer	5.66e-05	0.00176	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	5.65e-05	0.00175	CbGpPWpGaD
Gemfibrozil—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	5.53e-05	0.00172	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	5.46e-05	0.00169	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—CYP11A1—uterine cancer	5.44e-05	0.00169	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	5.38e-05	0.00167	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	5.38e-05	0.00167	CbGpPWpGaD
Gemfibrozil—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	5.27e-05	0.00164	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	5.2e-05	0.00162	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	5.15e-05	0.0016	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—AKR1C3—uterine cancer	5.13e-05	0.00159	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—AKR1B1—uterine cancer	5.13e-05	0.00159	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—STAR—uterine cancer	5.13e-05	0.00159	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	5.07e-05	0.00157	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—ERBB2—uterine cancer	4.93e-05	0.00153	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	4.86e-05	0.00151	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	4.86e-05	0.00151	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—CDKN2B—uterine cancer	4.61e-05	0.00143	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	4.6e-05	0.00143	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	4.6e-05	0.00143	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	4.33e-05	0.00135	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—CTNNB1—uterine cancer	4.31e-05	0.00134	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—SMAD3—uterine cancer	4.21e-05	0.00131	CbGpPWpGaD
Gemfibrozil—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	4.13e-05	0.00128	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—NDUFB11—uterine cancer	4.07e-05	0.00127	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—SRD5A2—uterine cancer	4.07e-05	0.00127	CbGpPWpGaD
Gemfibrozil—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	4.07e-05	0.00126	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—POLD1—uterine cancer	4.02e-05	0.00125	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	4.01e-05	0.00125	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—EP300—uterine cancer	4.01e-05	0.00124	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—STK11—uterine cancer	4e-05	0.00124	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—CYP19A1—uterine cancer	4e-05	0.00124	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.96e-05	0.00123	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.95e-05	0.00123	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—VEGFA—uterine cancer	3.8e-05	0.00118	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—AKR1C1—uterine cancer	3.76e-05	0.00117	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.75e-05	0.00117	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—NRAS—uterine cancer	3.75e-05	0.00116	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.74e-05	0.00116	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—SRD5A2—uterine cancer	3.64e-05	0.00113	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—NDUFB11—uterine cancer	3.64e-05	0.00113	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.58e-05	0.00111	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.53e-05	0.0011	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—ESR1—uterine cancer	3.44e-05	0.00107	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.38e-05	0.00105	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—RRM2—uterine cancer	3.35e-05	0.00104	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.34e-05	0.00104	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—NDUFB11—uterine cancer	3.32e-05	0.00103	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—SRD5A2—uterine cancer	3.32e-05	0.00103	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—DCN—uterine cancer	3.26e-05	0.00101	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—KRAS—uterine cancer	3.23e-05	0.001	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.22e-05	0.001	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CYP11A1—uterine cancer	3.07e-05	0.000953	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.04e-05	0.000945	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—MTHFR—uterine cancer	3.01e-05	0.000933	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—STAR—uterine cancer	2.95e-05	0.000915	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—AKR1B1—uterine cancer	2.95e-05	0.000915	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.91e-05	0.000904	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—AKR1C3—uterine cancer	2.9e-05	0.0009	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—SRD5A2—uterine cancer	2.83e-05	0.00088	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—NDUFB11—uterine cancer	2.83e-05	0.00088	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.75e-05	0.000855	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—HRAS—uterine cancer	2.74e-05	0.000852	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.65e-05	0.000823	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—AKR1B1—uterine cancer	2.63e-05	0.000817	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—STAR—uterine cancer	2.63e-05	0.000817	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.6e-05	0.000807	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.6e-05	0.000807	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—AKT1—uterine cancer	2.42e-05	0.000752	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—STAR—uterine cancer	2.4e-05	0.000745	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—AKR1B1—uterine cancer	2.4e-05	0.000745	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.37e-05	0.000736	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—POLD1—uterine cancer	2.31e-05	0.000718	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CYP19A1—uterine cancer	2.26e-05	0.000701	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—STK11—uterine cancer	2.26e-05	0.000701	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NDUFB11—uterine cancer	2.19e-05	0.000679	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—SRD5A2—uterine cancer	2.19e-05	0.000679	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—AKR1C1—uterine cancer	2.16e-05	0.000672	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.12e-05	0.000658	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—POLD1—uterine cancer	2.06e-05	0.000641	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—STAR—uterine cancer	2.05e-05	0.000636	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—AKR1B1—uterine cancer	2.05e-05	0.000636	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.03e-05	0.000629	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.02e-05	0.000627	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—AKR1C1—uterine cancer	1.93e-05	0.000599	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—RRM2—uterine cancer	1.93e-05	0.000599	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—POLD1—uterine cancer	1.88e-05	0.000584	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—DCN—uterine cancer	1.87e-05	0.000581	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CYP11A1—uterine cancer	1.76e-05	0.000547	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—AKR1C1—uterine cancer	1.76e-05	0.000547	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—RRM2—uterine cancer	1.72e-05	0.000534	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—MTHFR—uterine cancer	1.7e-05	0.000527	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PTEN—uterine cancer	1.67e-05	0.000519	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—DCN—uterine cancer	1.67e-05	0.000519	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—AKR1C3—uterine cancer	1.66e-05	0.000517	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—POLD1—uterine cancer	1.61e-05	0.000499	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—EP300—uterine cancer	1.59e-05	0.000495	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.58e-05	0.000491	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—STAR—uterine cancer	1.58e-05	0.000491	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CYP11A1—uterine cancer	1.57e-05	0.000489	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—RRM2—uterine cancer	1.57e-05	0.000487	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—DCN—uterine cancer	1.52e-05	0.000473	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—AKR1C1—uterine cancer	1.5e-05	0.000467	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.49e-05	0.000464	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—AKR1C3—uterine cancer	1.49e-05	0.000461	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYP11A1—uterine cancer	1.43e-05	0.000446	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—AKR1C3—uterine cancer	1.35e-05	0.000421	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—RRM2—uterine cancer	1.34e-05	0.000416	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—DCN—uterine cancer	1.3e-05	0.000404	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—STK11—uterine cancer	1.3e-05	0.000403	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CYP19A1—uterine cancer	1.3e-05	0.000403	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—POLD1—uterine cancer	1.24e-05	0.000385	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—AKT1—uterine cancer	1.24e-05	0.000385	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP11A1—uterine cancer	1.23e-05	0.000381	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.22e-05	0.000378	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PIK3CA—uterine cancer	1.18e-05	0.000366	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.16e-05	0.000361	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.16e-05	0.00036	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—AKR1C3—uterine cancer	1.16e-05	0.00036	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—STK11—uterine cancer	1.16e-05	0.00036	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CYP19A1—uterine cancer	1.16e-05	0.00036	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.09e-05	0.000337	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYP19A1—uterine cancer	1.06e-05	0.000328	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—STK11—uterine cancer	1.06e-05	0.000328	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.04e-05	0.000322	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—RRM2—uterine cancer	1.03e-05	0.000321	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—DCN—uterine cancer	1e-05	0.000312	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	9.91e-06	0.000308	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—MTHFR—uterine cancer	9.75e-06	0.000303	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—AKT1—uterine cancer	9.64e-06	0.000299	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP11A1—uterine cancer	9.46e-06	0.000294	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.45e-06	0.000293	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PTEN—uterine cancer	9.44e-06	0.000293	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—STK11—uterine cancer	9.02e-06	0.00028	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP19A1—uterine cancer	9.02e-06	0.00028	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—EP300—uterine cancer	9e-06	0.000279	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—AKR1C3—uterine cancer	8.94e-06	0.000277	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—MTHFR—uterine cancer	8.7e-06	0.00027	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	8.59e-06	0.000267	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	8.47e-06	0.000263	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	8.07e-06	0.000251	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—MTHFR—uterine cancer	7.93e-06	0.000246	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.67e-06	0.000238	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.99e-06	0.000217	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—STK11—uterine cancer	6.96e-06	0.000216	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP19A1—uterine cancer	6.96e-06	0.000216	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—MTHFR—uterine cancer	6.78e-06	0.00021	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PIK3CA—uterine cancer	6.66e-06	0.000207	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.97e-06	0.000185	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—AKT1—uterine cancer	5.44e-06	0.000169	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PTEN—uterine cancer	5.42e-06	0.000168	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—MTHFR—uterine cancer	5.23e-06	0.000162	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—EP300—uterine cancer	5.17e-06	0.000161	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PTEN—uterine cancer	4.84e-06	0.00015	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—EP300—uterine cancer	4.62e-06	0.000143	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PTEN—uterine cancer	4.41e-06	0.000137	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—EP300—uterine cancer	4.21e-06	0.000131	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PIK3CA—uterine cancer	3.82e-06	0.000119	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PTEN—uterine cancer	3.77e-06	0.000117	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—EP300—uterine cancer	3.6e-06	0.000112	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PIK3CA—uterine cancer	3.41e-06	0.000106	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—AKT1—uterine cancer	3.12e-06	9.7e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PIK3CA—uterine cancer	3.11e-06	9.67e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PTEN—uterine cancer	2.91e-06	9.04e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—AKT1—uterine cancer	2.79e-06	8.66e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—EP300—uterine cancer	2.78e-06	8.62e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PIK3CA—uterine cancer	2.66e-06	8.26e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—AKT1—uterine cancer	2.54e-06	7.9e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—AKT1—uterine cancer	2.17e-06	6.75e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PIK3CA—uterine cancer	2.05e-06	6.38e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—AKT1—uterine cancer	1.68e-06	5.21e-05	CbGpPWpGaD
